These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36499174)

  • 1. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
    Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro.
    Li Y; Wei Y; Li G; Huang S; Xu J; Ding Q; Hong J
    Transl Vis Sci Technol; 2022 Feb; 11(2):8. PubMed ID: 35119473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
    van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
    PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture].
    Karpov DS; Karpov VL; Klimova RR; Demidova NA; Kushch AA
    Mol Biol (Mosk); 2019; 53(1):91-100. PubMed ID: 30895956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.
    Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J
    Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.
    Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
    Elife; 2019 Dec; 8():. PubMed ID: 31789594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
    Zhang I; Hsiao Z; Liu F
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Optimization of Herpes Simplex Virus Vectors for Central Nervous System Gene Delivery based on CRISPR/Cas9-mediated Genome Editing.
    Huang X; Li X; Yang L; Wang P; Yan J; Nie Z; Gao Y; Li Z; Wen J; Cao X
    Curr Gene Ther; 2022; 22(1):66-77. PubMed ID: 34148538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Color CRISPR Imaging Reveals Dynamics of Herpes Simplex Virus 1 Replication Compartments and Virus-Host Interactions.
    Xu H; Wang J; Deng Y; Hou F; Fu Y; Chen S; Zou W; Pan D; Chen B
    J Virol; 2022 Dec; 96(24):e0092022. PubMed ID: 36453882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and validation of recombinant herpes simplex type 1 viruses (HSV-1) using CRISPR/Cas9 genetic disruption.
    Bommareddy PK; Peters C; Kaufman HL
    Methods Enzymol; 2020; 635():167-184. PubMed ID: 32122544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 Mutagenesis of UL21 in Multiple Strains of Herpes Simplex Virus Reveals Differential Requirements for pUL21 in Viral Replication.
    Finnen RL; Banfield BW
    Viruses; 2018 May; 10(5):. PubMed ID: 29762484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene editing and elimination of latent herpes simplex virus in vivo.
    Aubert M; Strongin DE; Roychoudhury P; Loprieno MA; Haick AK; Klouser LM; Stensland L; Huang ML; Makhsous N; Tait A; De Silva Feelixge HS; Galetto R; Duchateau P; Greninger AL; Stone D; Jerome KR
    Nat Commun; 2020 Aug; 11(1):4148. PubMed ID: 32811834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Based Genome Editing of HSV.
    Velusamy T; Gowripalan A; Tscharke DC
    Methods Mol Biol; 2020; 2060():169-183. PubMed ID: 31617178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Mediated Viral Gene Knockout to Investigate Viral Evasion of Antiviral Innate Immunity.
    Feng Z; Shen Y; Zheng C; Chen Q
    Methods Mol Biol; 2025; 2854():41-50. PubMed ID: 39192117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro.
    Vasques Raposo J; Rodrigues Carvalho Barros L; Ribas Torres L; Barbosa da Silva Pinto R; De Oliveira Lopes A; Mello de Souza E; Hernan Bonamino M; Salete de Paula V
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):19-23. PubMed ID: 37715442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing oncolytic
    Ebrahimi S; Makvandi M; Abbasi S; Azadmanesh K; Teimoori A
    Iran J Basic Med Sci; 2020 Jul; 23(7):937-944. PubMed ID: 32774817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Method for CRISPR/Cas9 Inhibition of a Human DNA Virus: Herpes Simplex Virus.
    Neuhausser WM; Oh HS; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
    Bio Protoc; 2020 Sep; 10(17):e3748. PubMed ID: 33659408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiviral activity of the organic germanium complex with aciclovir against herpes simplex virus (Herpesviridae: Alphaherpesvirinae: Simplexvirus: Human alphaherpesvirus 1/2) in the in vitro and in vivo systems].
    Alimbarova LM; Ambrosov IV; Matelo SK; Barinsky IF
    Vopr Virusol; 2021 Nov; 66(5):368-382. PubMed ID: 34738452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice.
    Yin D; Ling S; Wang D; Dai Y; Jiang H; Zhou X; Paludan SR; Hong J; Cai Y
    Nat Biotechnol; 2021 May; 39(5):567-577. PubMed ID: 33432198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.